Nonetheless, this strategy leads to overtreatment and missed therapy as nearly all STIs are asymptomatic. Therefore, WHO recommends countries to improve syndromic administration by slowly incorporating laboratory testing to support analysis. In options in which quality assured molecular assays are offered, it is suggested to treat STIs according to laboratory https://hc6.org/